Aducanumab: Appropriate Use Recommendations by Cummings, Jeffrey, Aisen, P., Apostolova, L. G., Atri, A., Salloway, S., Weiner, M.

Get full text

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group by Dubois, Bruno, Villain, Nicolas, Frisoni, Giovanni B, Rabinovici, Gil D, Sabbagh, Marwan, Cappa, Stefano, Bejanin, Alexandre, Bombois, Stéphanie, Epelbaum, Stéphane, Teichmann, Marc, Habert, Marie-Odile, Nordberg, Agneta, Blennow, Kaj, Galasko, Douglas, Stern, Yaakov, Rowe, Christopher C, Salloway, Stephen, Schneider, Lon S, Cummings, Jeffrey L, Feldman, Howard H

Get full text

Lecanemab: Appropriate Use Recommendations by Cummings, J., Apostolova, L., Rabinovici, G. D., Atri, A., Aisen, P., Greenberg, S., Hendrix, S., Selkoe, D., Weiner, M., Petersen, R. C., Salloway, S.

Get full text

Aducanumab: Appropriate Use Recommendations Update by Cummings, Jeffrey, Rabinovici, G. D., Atri, A., Aisen, P., Apostolova, L. G., Hendrix, S., Sabbagh, M., Selkoe, D., Weiner, M., Salloway, S.

Get full text

Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial by Mills, S.M., Mallmann, J., Santacruz, A.M., Fuqua, A., Carril, M., Aisen, P.S., Althage, M.C., Belyew, S., Benzinger, T.L., Brooks, W.S., Buckles, V.D., Cairns, N.J., Clifford, D., Danek, A., Fagan, A.M., Farlow, M., Fox, N., Ghetti, B., Goate, A.M., Heinrichs, D., Hornbeck, R., Jack, C., Jucker, M., Klunk, W.E., Marcus, D.S., Martins, R.N., Masters, C.M., Mayeux, R., McDade, E., Morris, J.C., Oliver, A., Ringman, J.M., Rossor, M.N., Salloway, S., Schofield, P.R., Snider, J., Snyder, P., Sperling, R.A., Stewart, C., Thomas, R.G., Xiong, C., Bateman, R.J.

Get full text

Gamma knife capsulotomy for intractable OCD: Neuroimage analysis of lesion size, location, and clinical response by McLaughlin, N C R, Magnotti, J F, Banks, G P, Nanda, P, Hoexter, M Q, Lopes, A C, Batistuzzo, M C, Asaad, W F, Stewart, C, Paulo, D, Noren, G, Greenberg, B D, Malloy, P, Salloway, S, Correia, S, Pathak, Y, Sheehan, J, Marsland, R, Gorgulho, A, De Salles, A, Miguel, E C, Rasmussen, S A, Sheth, S A

Get full text

The Future of Anti-Amyloid Trials by Aisen, P. S., Cummings, J., Doody, R., Kramer, L., Salloway, S., Selkoe, D. J., Sims, J., Sperling, R. A., Vellas, B.

Get full text

MR imaging features of amyloid-related imaging abnormalities by Barakos, J, Sperling, R, Salloway, S, Jack, C, Gass, A, Fiebach, J B, Tampieri, D, Melançon, D, Miaux, Y, Rippon, G, Black, R, Lu, Y, Brashear, H R, Arrighi, H M, Morris, K A, Grundman, M

Get full text

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval by Howe, Matthew D., Britton, K. J., Joyce, H. E., Pappas, G. J., Faust, M. A., Dawson, B. C., Riddle, M. C., Salloway, S. P.

Get full text

The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer’s Prevention Registry by Lee, Athene K. W., Collier, M. K., Thompson, L. I., Popescu, D., Arthur, E., Correia, S., Salloway, S. P., Alber, J.

Get full text

Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report by Bateman, Randall J., Blennow, K., Doody, R., Hendrix, S., Lovestone, S., Salloway, S., Schindler, R., Weiner, M., Zetterberg, H., Aisen, P., Vellas, B.

Get full text

Combination Therapy for Alzheimer’s Disease: Perspectives of the EU/US CTAD Task Force by Gauthier, Serge, Alam, J., Fillit, H., Iwatsubo, T., Liu-Seifert, H., Sabbagh, M., Salloway, S., Sampaio, C., Sims, J. R., Sperling, B., Sperling, R., Welsh-Bohmer, K. A., Touchon, J., Vellas, B., Aisen, P.

Get full text

Alzheimer’s Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer’s Clinical Trial Consortium Sites by Rhodus, Elizabeth K., Aisen, P., Grill, J. D., Rentz, D. M., Petersen, R. C., Sperling, R. A., Salloway, S. P., Pierce, D., Raman, R.

Get full text

Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force by Angioni, D., Hansson, O., Bateman, R. J., Rabe, C., Toloue, M., Braunstein, J. B., Agus, S., Sims, J. R., Bittner, T., Carrillo, M. C., Fillit, H., Masters, C. L., Salloway, S., Aisen, P., Weiner, M., Vellas, B., Gauthier, S., Abushakra, Susan, Afshar, Mohammad, Alam, John, Algeciras-Schimnich, Alicia, Andrieu, Sandrine, Ballard, Clive, Baruch, Amos, Batrla, Richard, Baudler, Monika, Bell, Joanne, Bozeat, Sasha, Brooks, Dawn, Brooks, Tricia, Bullain, Szofia, Burmeister, Jan, Cho, Min, Collins, Emily, Cook, Gavin, Cummings, Jeffrey, Dague, Chris, De Santi, Susan, Doody, Rachelle, Dunn, Billy, Egan, Michael, Eriksson, Sven, Esquivel, Rianne, Fagan, Tom, Ferrell, Phyllis, Gallagher, Michela, Grönblad, Anna-Kaija, Hains, Avis, Hampel, Harald, Hefting, Nanco, Hendrix, Suzanne, Ho, Carole, Hu, Helen, Ismail, Zahinoor, Jones, Daryl, Kinney, Gene, Kinnon, Paul, Kurzman, Ricky, Lannfelt, Lars, Lawson, John, LeBastard, Nathalie, Lewandowski, Nicole, Lim, Carine, Lyketsos, Costantine, Masterman, Donna, Lu, Ming, Mintun, Mark, Molinuevo, José Luis, Monteiro, Cecilia, Navia, Bradford, Odergren, Tomas, Osswald, Gunilla, Penny, Lewis, Pontecorvo, Michael, Porsteinsson, Anton, Raman, Rema, Respondek, Gesine, Reyderman, Larisa, Rogers, Sharon, Rosenberg, Paul, Rosenzweig-Lipson, Sharon, Roskey, Mark, Saad, Ziad, Schindler, Rachel, Selkoe, Dennis, Shulman, Melanie, Sink, Kaycee, Sipe, Lisa, Skovronsky, Daniel, Somers, Elizabeth, Soto, Maria, Streffer, Johannes, Such, Pedro, Suhy, Joyce, Touchon, Jacques, Vandijck, Manu, White, Anne, Wilson, David, Zago, Wagner, Zhou, Jin

Get full text

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease by Hansson, Oskar, Edelmayer, Rebecca M., Boxer, Adam L., Carrillo, Maria C., Mielke, Michelle M., Rabinovici, Gil D., Salloway, Stephen, Sperling, Reisa, Zetterberg, Henrik, Teunissen, Charlotte E.

Get full text

Spontaneous lobar haemorrhage in CADASIL by MacLean, A V, Woods, R, Alderson, L M, Salloway, S P, Correia, S, Cortez, S, Stopa, E G

Get full text

Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease by Salloway, S, Gur, T, Berzin, T, Zipser, B, Correia, S, Hovanesian, V, Fallon, J, Kuo-Leblanc, V, Glass, D, Hulette, C, Rosenberg, C, Vitek, M, Stopa, E

Get full text

Donepezil in Vascular Dementia: Combined Analysis of Two Large-Scale Clinical Trials by Román, Gustavo C., Wilkinson, David G., Doody, Rachelle S., Black, Sandra E., Salloway, Stephen P., Schindler, Rachel J.

Get full text

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria by Dubois, Bruno, Prof, Feldman, Howard H, Prof, Jacova, Claudia, PhD, Hampel, Harald, Prof, Molinuevo, José Luis, MD, Blennow, Kaj, MD, DeKosky, Steven T, Prof, Gauthier, Serge, Prof, Selkoe, Dennis, Prof, Bateman, Randall, MD, Cappa, Stefano, MD, Crutch, Sebastian, PhD, Engelborghs, Sebastiaan, MD, Frisoni, Giovanni B, Prof, Fox, Nick C, MD, Galasko, Douglas, Prof, Habert, Marie-Odile, MD, Jicha, Gregory A, MD, Nordberg, Agneta, MD, Pasquier, Florence, Prof, Rabinovici, Gil, MD, Robert, Philippe, Prof, Rowe, Christopher, MD, Salloway, Stephen, Prof, Sarazin, Marie, Prof, Epelbaum, Stéphane, MD, de Souza, Leonardo C, MD, Vellas, Bruno, Prof, Visser, Pieter J, MD, Schneider, Lon, Prof, Stern, Yaakov, Prof, Scheltens, Philip, Prof, Cummings, Jeffrey L, Prof

Get full text

What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force by Aisen, P. S., Siemers, E., Michelson, D., Salloway, S., Sampaio, C., Carrillo, M. C., Sperling, R., Doody, R., Scheltens, P., Bateman, R., Weiner, M., Vellas, B.

Get full text